These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 19179082)

  • 1. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
    Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
    Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor.
    Boojamra CG; Mackman RL; Markevitch DY; Prasad V; Ray AS; Douglas J; Grant D; Kim CU; Cihlar T
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1120-3. PubMed ID: 18164198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates.
    Mackman RL; Boojamra CG; Prasad V; Zhang L; Lin KY; Petrakovsky O; Babusis D; Chen J; Douglas J; Grant D; Hui HC; Kim CU; Markevitch DY; Vela J; Ray A; Cihlar T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6785-9. PubMed ID: 18029175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs.
    Mackman RL; Zhang L; Prasad V; Boojamra CG; Douglas J; Grant D; Hui H; Kim CU; Laflamme G; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
    Bioorg Med Chem; 2007 Aug; 15(16):5519-28. PubMed ID: 17562366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase.
    Liu X; Xie W; Huang RH
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-HIV activity of cyclic pyrimidine phosphonomethoxy nucleosides and their prodrugs: a comparison of phosphonates and corresponding nucleosides.
    Mackman RL; Zhang L; Prasad V; Boojamra CG; Chen J; Douglas J; Grant D; Laflamme G; Hui H; Kim CU; Parrish J; Stoycheva AD; Swaminathan S; Wang K; Cihlar T
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):573-7. PubMed ID: 18066858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters.
    Romanowska J; Szymańska-Michalak A; Boryski J; Stawiński J; Kraszewski A; Loddo R; Sanna G; Collu G; Secci B; La Colla P
    Bioorg Med Chem; 2009 May; 17(9):3489-98. PubMed ID: 19282192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
    Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
    J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
    J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
    Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
    J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
    Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
    Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides.
    Romeo G; Iannazzo D; Piperno A; Romeo R; Saglimbeni M; Chiacchio MA; Balestrieri E; Macchi B; Mastino A
    Bioorg Med Chem; 2006 Jun; 14(11):3818-24. PubMed ID: 16480883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of dually branched 5'-norcarbocyclic adenosine phosphonodiester analogue as a new anti-HIV prodrug.
    Oh CH; Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Oct; 29(10):721-33. PubMed ID: 20924954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides: novel inhibitors of reverse transcriptase.
    Chiacchio U; Balestrieri E; Macchi B; Iannazzo D; Piperno A; Rescifina A; Romeo R; Saglimbeni M; Sciortino MT; Valveri V; Mastino A; Romeo G
    J Med Chem; 2005 Mar; 48(5):1389-94. PubMed ID: 15743182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents.
    Keane SJ; Ford A; Mullins ND; Maguire NM; Legigan T; Balzarini J; Maguire AR
    J Org Chem; 2015 Mar; 80(5):2479-93. PubMed ID: 25532055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
    Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
    J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.